These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 53014)
1. Biochemical aspects of schizophrenia. Stewart BM Am J Nurs; 1975 Dec; 75(12):2176-9. PubMed ID: 53014 [No Abstract] [Full Text] [Related]
2. [Biochemical aspects of schizophrenia]. Stewart BM Tijdschr Ziekenverpl; 1977 Nov; 30(23):1082-7. PubMed ID: 74865 [No Abstract] [Full Text] [Related]
3. Schizophrenia--new concepts. Gottlieb JS; Frohman CE; Harmison CR South Med J; 1971 Jun; 64(6):743-9. PubMed ID: 4103649 [No Abstract] [Full Text] [Related]
4. [Research into the biochemical bases of schizophrenic syndromes: a review]. Laplante M; St-Laurent J Union Med Can; 1973 Nov; 102(11):2267-78. PubMed ID: 4134633 [No Abstract] [Full Text] [Related]
5. [Biochemical and physiopathological bases of the study of tryptophan metabolism in schizophrenia]. Dogaru C; Grecu S Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1984; 29(2):141-50. PubMed ID: 6238390 [No Abstract] [Full Text] [Related]
6. Disturbances in tryptophan and serotonin metabolism in affective psychoses and schizophrenia. Puzyński S; Jakomow B Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):47-60. PubMed ID: 1107970 [No Abstract] [Full Text] [Related]
7. [Tryptophan and its metabolism in schizophrenia]. Szafranek J; Szafranek K Psychiatr Pol; 1970; 4(5):585-8. PubMed ID: 4921675 [No Abstract] [Full Text] [Related]
8. Electrophysiological phenomena associated with the S-protein system in normal and schizophrenic subjects. Cowen MA Biol Psychiatry; 1973 Oct; 7(2):113-27. PubMed ID: 4127122 [No Abstract] [Full Text] [Related]
10. Biochemical and clinical changes resulting from administration of marsilid and tryptophan to schizophrenic patients; biochemical aspects. ZELLER EA J Clin Exp Psychopathol; 1958; 19(2, Suppl. 1):106-9. PubMed ID: 13549574 [No Abstract] [Full Text] [Related]
11. [Current biochemical conceptions of mental disorders. I. Biogenic amines in the pathogenesis of schizophrenia]. Anokhina IP; Gamaleia NB Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1096-1105. PubMed ID: 384732 [No Abstract] [Full Text] [Related]
12. Biochemical and clinical changes resulting from administration of marsilid and tryptophan to schizophrenic patients; the clinical aspects. LAUER JW J Clin Exp Psychopathol; 1958; 19(2, Suppl. 1):110-3. PubMed ID: 13549575 [No Abstract] [Full Text] [Related]
13. Amino acid transport and the plasma factor in schizophrenia. Frohman CE; Warner KA; Barry CT; Arthur RE Biol Psychiatry; 1969 Jul; 1(3):201-7. PubMed ID: 4187516 [No Abstract] [Full Text] [Related]
14. Distribution and mechanism of action of the anti-S protein in human brain. Frohman CE; Arthur RE; Yoon HS; Gottlieb JS Biol Psychiatry; 1973 Aug; 7(1):53-61. PubMed ID: 4127168 [No Abstract] [Full Text] [Related]
15. [The role of nicotinic acid and its derivatives in the etiopathogenesis of schizophrenia]. Slowik S Psychiatr Pol; 1969; 3(1):89-95. PubMed ID: 4389305 [No Abstract] [Full Text] [Related]
16. [Hypothetical concept: the physiopathological entity of monoaminergic psychoses]. Tissot R Encephale; 1975; 1(4):289-339. PubMed ID: 1082812 [TBL] [Abstract][Full Text] [Related]
18. Investigations on ceruloplasmin in chronic schizophrenia. Puzyński S Pol Med J; 1966; 5(6):1484-91. PubMed ID: 4166118 [No Abstract] [Full Text] [Related]
19. [Various biochemical aspects of the concept of inhibition in psychiatry]. Tissot R Encephale; 1978; 4(5 Suppl):513-20. PubMed ID: 753613 [TBL] [Abstract][Full Text] [Related]